Statutory instrument laid in the House of Commons and House of Lords, on Thursday, 1 April 2004 on behalf of the Department of Health. It was made on Wednesday, 31 March 2004.
Medicines for Human Use (Clinical Trials) Regulations 2004
SI 2004/1031 (Negative instrument). Coming into force 1 May 2004.
Secondary information
- Type
- Statutory instrument
- Reference
- SI 2004/1031
- Session
- 2003-04
- Coming into force
- Saturday, 1 May 2004
- Procedure
- Negative
- Related items
-
Medicines for Human Use (Clinical Trials) and Blood Safety and Quality (Amendment) Regulations 2008
Monday, 7 April 2008
Statutory instruments
House of Commons
House of Lords
- EC documents
- DIR2001/20/EC
- Notes
- DEBATE: LH 19 MAY 2004; SC (1ST) 25 MAY 2004
- Subjects
- Children Disclosure of information Appeals Applications Committees Licensing Inspections Enforcement Genetics EU law Drugs Labelling Ethics Imports Powers Membership Mental capacity Monitoring Regulation Safety Side effects Sponsorship Medicines Commission United Kingdom Ethics Committees Authority Manufactured goods Clinical trials
- Legislation
- European Communities Act 1972
- Medicines for Human Use (Clinical Trials) Regulations 2004
- Library location
- Commons Library: UP 667 2003/04
- Link
- View this Statutory instrument on www.legislation.gov.uk
Librarians' tools
- Timestamp
- 2025-05-20 09:07:02 +0100
- URI
- http://data.parliament.uk/pimsdata/StatutoryInstrument/1293
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/StatutoryInstrument/1293
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/StatutoryInstrument/1293